At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Biotrue MPS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions
In Brief
A clinical study evaluating Biotrue MPS and Investigational MPS for Corneal Staining. Completed, enrolled 30 participants across 1 site.
Detailed Summary
An investigational multi-purpose solution (MPS)was clinically evaluated against Biotrue MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCorneal Staining
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedNov 2010
Primary CompletionNov 2010
TodayJul 2026
First PostedNov 15, 2010
Enrollment StartAug 31, 2010
Primary CompletionNov 30, 2010
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.6 years ago
Interventions
Biotrue MPSdevice
Multi-purpose contact lens care solution
Investigational MPSdevice
Multi-purpose contact lens care solution